相关实验视频

Updated: Jun 28, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

816

对抗MAG神经病症治疗的自身抗体反应的时间过程:两个病例报告

Angelica C Cornejo1, Norman Latov1

  • 1New York - Presbyterian/Weill Cornell Medicine, USA.

Heliyon
|April 11, 2024
PubMed
概括

用Rituximab治疗抗髓质蛋白关联糖蛋白 (MAG) 神经病的治疗可能需要长期治疗一年以上,以显著降低自身抗体水平. 长期治疗可以有效地降低这种罕见的神经疾病患者的抗体度.

关键词:
抗MAG是一种抗MAG药物.案例报告案例报告脱叶林化神经病变是一种神经病变.

更多相关视频

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.3K

相关概念视频

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K